NUWIQ Trademark
Serial Number: 79138098 • Registration: 4496748
NUWIQ is a trademark filed by
Octapharma AG
on August 9, 2013. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
August 9, 2013
Registration Date
March 18, 2014
Published for Opposition
December 31, 2013
Goods & Services
Pharmaceutical products, namely blood coagulation factors, particularly recombinant factors VIII
Filing History
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sep 25, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
Sep 25, 2024 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 23, 2024 APRE
TEAS SECTION 71 RECEIVED
Jan 12, 2024 ES71
INTERNATIONAL REGISTRATION RENEWED
Aug 10, 2023 RNWL
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 18, 2023 REM4
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Apr 11, 2020 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Apr 10, 2020 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 1, 2020 APRE
TEAS SECTION 71 & 15 RECEIVED
Feb 14, 2020 ES75
NEW REPRESENTATIVE AT IB RECEIVED
Aug 18, 2016 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Aug 11, 2016 NREP
NOTIFICATION PROCESSED BY IB
Jul 4, 2014 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jun 5, 2014 FICS
FINAL DISPOSITION PROCESSED
Jun 5, 2014 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Apr 17, 2014 GPAR
REGISTERED-PRINCIPAL REGISTER
Mar 18, 2014 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Jan 3, 2014 NREP
NOTIFICATION PROCESSED BY IB
Dec 31, 2013 GPNX
PUBLISHED FOR OPPOSITION
Dec 31, 2013 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 11, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 11, 2013 OP2R
NOTICE OF PUBLICATION
Dec 11, 2013 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 25, 2013 CNSA
ASSIGNED TO EXAMINER
Nov 25, 2013 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 16, 2013 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 12, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 11, 2013 REPR
